Confidential · Strategic Growth Round · 2026
01 / 12

Investor Presentation

Confidential access

HYRO
Strategic growth round 2026

Australia's premium hydration brand.

Built for the next billion-dollar exit window. A$3M to A$5M strategic growth round at approximately A$30M post-money.

A$3M to A$5M round~A$30M post-moneyFounder-led process
Hyro product range
ConfidentialMay 2026
FAST
Investment snapshot

Real recurring revenue, real unit economics, real category timing.

A$7.14M
AU subscription ARR, ex GST
9,111
Active subscribers
+1,421
Trailing 30-day net subscriber adds
78%
April 2026 cohort sub attach rate
3.55x
M16 GP LTV:CAC, actual

Capital funds the United States launch, retention engineering, retail acceleration and the next hero SKU.

NOW
Why now

The category just paid out twice.

Strategic appetite is here

  • Unilever acquired Grüns for approximately US$1.2B in April 2026 after roughly 24 months.
  • Liquid I.V. proved the strategic exit path before it.
  • IM8 reportedly reached approximately US$120M ARR in twelve months.

Hyro fits the pattern

  • Premium daily wellness format with repeat-use behaviour.
  • Subscription-native revenue from day one.
  • Creator-investor distribution instead of paid-post dependency.
  • AI operating leverage that compresses team cost and execution time.
WatermelonBlackcurrantVariety
Subscription wins the wellness shelf

Hyro is built around recurring revenue from day one.

The strongest hydration brands are habit brands. Hyro has already turned flavour-led hydration into a subscription engine with lifetime gross-profit economics, not just transactional gross profit.

What has been proven

  • A$595K active product MRR ex GST.
  • A$65.31 ARPU per subscriber.
  • Three-month gross-profit payback.

Why it matters

  • More valuable revenue mix.
  • Cleaner cohort visibility.
  • Retention engine improving with scale.
PROOF
The proof stack

Investor-grade metrics across revenue, margin, acquisition and retention.

A$4.13M
FY25-26 revenue ex GST
A$9-10M
Forward run rate, combined
57%
Gross margin, FY25-26
A$68
Weighted-average subscriber CAC
A$880
Mar-Apr 2026 cohort M36 LTV forecast
6.11x
GP LTV:CAC, month 36 forecast
150+
Wholesale accounts onboarded
17,894
Subscribers in reconciled cohort dataset
RANGE
Product, formula and positioning

The formula carries the brand.

Hyro sits between medical hydration, sports drinks and premium wellness powders. Clinical-grade electrolyte load, zero added sugar, priced for daily use. The taste and design earn the repeat, the formula earns the trust.

500mg
Sodium
250mg
Potassium
100mg
Magnesium
0g
Added sugar
10
Calories per stick
BrandPositioningSodiumAdded sugarCost / serve AU
HyroPlayful performance500mg0g~A$1.07, ~A$0.85 on sub
Liquid I.V.Medical hydration510mg11g~A$2.40
HydralyteSick-day rehydration490mg2g~A$1.50
GatoradeSports performance270mg21g~A$3.50
LMNTKeto / endurance1,000mg0g~A$3.00

Source: competitor brand websites and Coles/Woolworths shelf checks, April 2026. Hyro delivers premium hydration at a daily-use price point, no premium cost burden on the customer.

Revenue trajectory

A$7K to A$750K monthly revenue in 23 months.

Controlled compounding, not a one-off spike. Revenue scaled 100x while ad spend stayed disciplined and ROAS held above 3x. This is the shape of a brand finding product-market fit, not buying it.

20.8%

Compound monthly growth across the tracked 24-month window.

3.0x

Blended ROAS maintained through scale and stockout periods.

$856K$642K$428K$214K$024/0524/0824/1125/0225/0525/0825/1126/0226/04RevenueAd spend
Subscription engine

From about 20 new subs a day to 100+ a day.

Hyro became structurally subscription-led once the team built the engine properly. April 2026 averaged roughly 94 new subs per day, with peaks above 100.

9,111
Active subscribers
+1,421
Net adds, trailing 30 days
A$595K
Active product MRR ex GST
10K8K5K3K0K24/0524/0824/1125/0225/0525/0825/1126/0226/04
Unit economics

11.6x gross LTV:CAC by month 36. Payback inside three months.

A$715
M36 gross LTV
A$61
Weighted CAC in cohort pack
6.81x
GP LTV:CAC, M36
2-3mo
GP payback window

LTV crosses CAC inside three months and compounds for the next 33. Payback this fast on a A$70 CAC is rare in DTC and rarer still in functional beverage.

$800$600$400$200$0M0M18M36
Cohort quality

As Hyro scales, the latest cohorts retain better.

The strongest signal in the dataset: Mar-Apr 2026 cohorts, our largest acquisition months ever, project above the weighted average LTV. Quality is improving as scale increases, the opposite of what usually happens.

Retention levers live

  • Win-back flows and Skio cancel-flow recovery.
  • Self-serve skip, swap, pause and flavour change.
  • First-30-day onboarding, lifecycle email and SMS.
  • Free-gift hold points at the highest attrition windows.
106%80%53%26%0%M0M8M16
Profitability architecture

Revenue, gross profit and operating leverage are visible.

Real revenue, real gross profit, real operating leverage. Margins expanding as the subscriber book matures. This is a business, not a marketing story.

57%

FY25-26 gross margin ex GST.

A$4.28M

Implied annual GP in the current subscriber book.

$842K$604K$366K$128K$-108KJulNovMar
SCALE
Path to scale and milestones

From A$10M run-rate today to a multi-market daily-routine platform.

FY27
A$25M

AU subs compounding, early US launch and Creatine live.

FY28
A$60M

US scaled, wholesale expanded and Creatine compounding.

FY29
A$200M

Multi-channel, multi-market daily-routine platform.

Active subscribers40,000+
Weighted subscriber CAC≤A$70
US DTC monthly revenueA$200K+
Wholesale accounts300+
New SKUCreatine
Concurrent global ads400+
Team, cap table and investor context

Founder-led, lean team, meaningful prior capital in.

Founder-led operating team

  • Steve Chapman, CEO and co-founder.
  • Taylor Chapman, co-founder.
  • Nicola, Nathan, Julia and Emma across CX, growth, creator and supply chain.

AI leverage

  • Hermes as chief-of-staff layer.
  • Apollo for growth and creative intelligence.
  • Atlas for supply chain and inventory.
  • Plutus and Lisa for finance and CS execution.

Cap table context

  • A$2.2M capital raised to date.
  • Prior round at A$8M pre-money.
  • Strategic creator-investor stack already in place.
Creator-investor distribution

Equity ambassadors, not paid posters.

Sarah's Day

1.3M+ audience. Co-creator of the hero flavour and a structural distribution partner.

Elite sport

Quade Cooper, Daly Cherry-Evans, Kendrick Louis and athlete network credibility.

Creator leverage

Dan Churchill plus a broader founder-led creator-investor network that compounds trust.

Hyro lifestyle
Distribution is structuralCommunity first
media second
2026
2026 revenue scenarios

Multiple ways to win in the next twelve months.

Base
A$12M
Target
A$15M
Upside
A$18M

Target bridge to A$15M

  • AU subscription: A$7.1M
  • One-time DTC: A$1.9M
  • Wholesale and retail: A$1.6M
  • US launch: A$2.0M
  • Creatine and new SKUs: A$2.4M

What the scenarios imply

  • The base case can be underwritten from an already scaled recurring engine.
  • The target case is mostly execution, not invention.
  • The upside case requires the US and new SKU engine to hit early.
US
United States launch

Australia proved the model. The US is the scale unlock.

The US Shopify Plus store is live. The brand already has proof in Australia. The round gives Hyro the inventory, creator activation and paid media fuel to move properly.

Launch infrastructure

  • US store live on drinkhyro.co.
  • US operating setup underway.
  • 3PL readiness being built.

Demand engine

  • Creator seeding and paid media.
  • Stage-gated to CAC and cohort proof.
  • AU learnings exported to a larger market.

Next hero SKU

  • Creatine and new SKUs expand the routine.
  • More reasons to subscribe.
  • More shelf and social relevance.
Internal AI operating system

Six-person team, fifteen-person throughput.

Hyro has an AI operating layer across growth, finance, supply chain, customer experience and founder leverage. This is a margin and speed lever in every function, not a tech bet.

Humans and roles

Steve ChapmanCEO, founder, capital and US launch.
Taylor ChapmanCo-founder, brand and product instinct.
NicolaCX, ops coordination and founder leverage.
NathanGrowth, CRO, lifecycle and US store.
JuliaCreators, ambassadors and social proof engine.
EmmaSupply chain, inventory and fulfilment rhythm.

AI agents

HermesChief-of-staff layer and execution orchestration.
ApolloGrowth intelligence, creative testing and paid rhythm.
AtlasSupply chain visibility, purchasing and inventory systems.
PlutusFinance cockpit, margins and capital allocation support.
LisaCustomer inbox execution and escalation discipline.
Use of funds

Capital goes directly into the next growth step.

US paid media and creator activation
58%
Inventory depth and 3PL readiness
14%
Creator operations and creative production
10%
US growth lead
10%
R&D, Creatine launch and working capital
8%
ROUND
Round structure

A curated round for strategic capital.

A$3M-A$5M
Round size
~A$30M
Post-money valuation anchor
10.0%-16.7%
Dilution range
A$2.2M
Capital raised to date
~4.2x
Multiple on AU subscription ARR

Implied multiples

  • ~3.0x to 3.3x on forward run rate.
  • ~2.0x on 2026 base revenue.
  • ~1.6x on 2026 target revenue.

What we are looking for

  • Category operating experience in functional wellness, beverage or recurring-revenue consumer.
  • US distribution or retail relationships.
  • Creator-led acquisition or athlete equity partnership depth.
  • Strategic acquirer context in the category.
Next step

IM v0.5 plus data room under NDA.

This round is not open to passive capital. The right investor helps Hyro turn a proven Australian subscription engine into a global hydration platform.

Steve
Chapman

Founder and CEO · Hyro

steve@drinkhyro.com
+61 420 315 541
hyro-raise.pages.dev